drugset
drugset / Trial / NCT04485884

A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects

NCT04485884 ↗

Phase 1 Unknown 42 enrolled HK inno.N Corporation
RandomizedSequentialOpen-labelTreatment

Summary

The main purpose of this study is to evaluate pharmacokinetics/pharmacodynamics and safety/tolerability of IN-C005 after oral administration in healthy Korean and Caucasian male subjects.

Timeline

Start
2020-08-13
Primary completion
2021-03
Completion
2021-06

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-C005 Unknown — Oral

Indications

No indication recorded.